Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...

Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned ...

One CEO said people should be using AI to understand their health much more than they already do.

The proposal, spearheaded by EU Health Commissioner Olivér Várhelyi, is intended to strengthen Europe’s life sciences sector, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

What's critical about this new facility is we currently have a situation in our healthcare and biotechnology programs where ...

Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease ...

Q1 2026 earnings call: commercialization timeline, EAP traction, service lab progress, cash runway through 2027 & risks.

Nuevocor, a biotechnology company that develops therapies for cardiomyopathies, has appointed Monica Shah, MD, as chief medical officer.  Dr. Shah is a heart failure and transplant cardiologist with ...

China’s National Biobank is one of the world’s largest and Beijing is pushing to make it the biggest. Read more at ...

Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported first quarter 2026 financial results ...